IL1A and pancreatic neoplasm: This finding was further confirmed by the observation that in pancreatic cancer, blocking the IL-1 pathway decouples SASP from other senescence-related phenotypes, thereby inhibiting macrophage recruitment in the TME and desmoplastic tissue generation, a hallmark of pancreatic cancer [80].